XYLOCAINE VISCOUS lidocaine (lignocaine) hydrochloride 21.4 mg/mL oral liquid (Reformulation)

Nazione: Australia

Lingua: inglese

Fonte: Department of Health (Therapeutic Goods Administration)

Principio attivo:

lidocaine hydrochloride monohydrate, Quantity: 21.4 mg/mL

Commercializzato da:

Aspen Pharmacare Australia Pty Ltd

INN (Nome Internazionale):

lidocaine (lignocaine) hydrochloride monohydrate

Forma farmaceutica:

Oral Liquid

Composizione:

Excipient Ingredients: carmellose sodium; propyl hydroxybenzoate; citric acid; purified water; sodium hydroxide; methyl hydroxybenzoate; saccharin sodium; Flavour

Via di somministrazione:

Buccal, Oral

Confezione:

100mL

Tipo di ricetta:

(S2) Pharmacy Medicine

Indicazioni terapeutiche:

Indicated for the relief of pain and discomfort associated with:,?irritated or inflamed mucous membranes of the mouth, pharynx and upper gastrointestinal tract, e.g. post-tonsillectomy sore throat, dumping syndrome;,?introduction of instruments and catheters into the respiratory and gastrointestinal tract.

Dettagli prodotto:

Visual Identification: Clear to almost clear slightly coloured viscous liquid; Container Type: Bottle; Container Material: LDPE; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius

Stato dell'autorizzazione:

Licence status A

Data dell'autorizzazione:

2013-08-14